Abstract

Tumor Immunology Studies on T cells within the tumor microenvironment have largely focused on T cells that express γδ T cell receptors (TCRs). Benveniste et al. used an in vitro culture system to expand melanoma antigen–specific T cells and identified γδ T cells that recognize melanoma antigens in a class I major histocompatibility complex (MHC)–restricted manner. They then crystallized one of these γδ TCRs complexed with cognate peptide, MHC, and β2 microglobulin. T cell–centric therapies have been successful in treating certain cancers. These results should contribute toward a closer examination of the role of γδ T cells in the tumor microenvironment of melanomas and other cancers. Sci. Immunol. 3 , eaav4036 (2018).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.